HITPC - Information Exchange Work GroupMeaningful Use Stage 3 Subgroup 1

Quality and Efficiency

Chair: Dave GoetzMembers: Cris Ross, Chris Tashjian, Steve Stack

How can these areas be addressed in the context of MU Stage 3?

• Administrative simplification• Clinical Decision Support• E-prescribing

• Questions:– Can the MU framework effectively be used to address those electronic

transactions not currently in Stage 1 or Stage 2 as proposed (admin)?– Which Stage 1 or Stage 2 (proposed) objectives should be expanded?– Are there new objectives that need to be created?– Are there Stage 1 or Stage 2 objectives to be deleted or consolidated?

Proposed short term thoughts

• Administrative simplification– Which transaction areas could be considered?

• Prior authorizations, eligibility checks, claims processing/editing– Which are already addressed in the market?– How would the MU framework address this area?

• What would be effective for EHR vendors and providers?

• Clinical Decision Support– Await final MU 2 regulations, recommendations from MU WG

• E-prescribing– What areas of eRx remain unaddressed? (controlled substances, mail

order pharmacies)